title: Long-term results of femoropopliteal bypass with stabilized human umbilical vein.
abstract: BACKGROUND
  Stabilized human umbilical vein (SHUV) is one of several graft materials that may be used when autogenous saphenous vein is absent or inadequate, or when a shortened anesthesia time is deemed necessary.
  
  
  METHODS
  Two hundred eleven consecutive femoropopliteal bypasses were used in 171 patients since 1977. Follow-up has been conducted at regular intervals since operation, and the results scrutinized according to operative indication, diabetic status, and the number of runoff vessels.
  
  
  RESULTS
  Life-table cumulative rates were 70 +/- 3%, 45 +/- 4%, and 26 +/- 5% at 1, 5, and 10 years, respectively. Patency rates for bypasses performed for claudication were superior to those performed for limb-salvage but achieved statistical significance at 1 and 3 years only. Early patency rates for nondiabetic patients were superior to those in patients with diabetes, but did not achieve statistical significance. The incidence of infection was 3%, and the incidence of aneurysm formation was 3.3%.
  
  
  CONCLUSIONS
  SHUV is an acceptable alternative for femoropopliteal bypass when autogenous saphenous vein is inadequate or unavailable.
authors.affiliation: University of Pittsburgh Medical Center, Pennsylvania.
authors.forename: F
authors.initials: F
authors.lastname: Jarrett
authors.forename: B A
authors.initials: BA
authors.lastname: Mahood
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000783:Aneurysm / Q000401:mortality / Q000601:surgery*; D017719:Diabetic Foot / Q000401:mortality / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D005260:Female; D005263:Femoral Artery / Q000601:surgery*; D005500:Follow-Up Studies; D005734:Gangrene; D006801:Humans; D007383:Intermittent Claudication / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D015993:Life Tables; D008297:Male; D008875:Middle Aged; D011150:Popliteal Artery / Q000601:surgery*; D011183:Postoperative Complications / Q000401:mortality / Q000503:physiopathology; D015996:Survival Rate; D013997:Time Factors; D014471:Umbilical Veins / Q000637:transplantation*; D014654:Vascular Patency